Oregon Health & Science University researchers have identified the gene behind a group of rare, progressive childhood disorders caused by an abnormal buildup of iron in the brain.
Discovery of the PLA2G6 gene, whose mutated forms trigger several genetic disorders categorized as neuroaxonal dystrophies, could shed light on the nerve cell degeneration that leads to such neurological maladies as Parkinson's and Alzheimer's diseases, both known to be associated with brain iron accumulation.
"If you're a family with a kid with one of these diseases, the impact is clear, specific and personal," said Susan J. Hayflick, M.D., professor of molecular and medical genetics, pediatrics and neurology in the OHSU School of Medicine. But because it may heighten understanding of other, better-known neurological disorders, "To the general population, (the discovery) has a larger impact, and that's a significant benefit."
In a study published online June 18 in the journal Nature Genetics, Hayflick and an international team of geneticists describe PLA2G6's discovery using DNA from families with infantile neuroaxonal dystrophy, or INAD, and a related disorder known as neurodegeneration with brain iron accumulation, or NBIA.
In INAD, also known as Seitelberger disease, symptoms start by age 2 and worsen over time, and include loss of head control and the ability to sit, crawl or walk, as well as deteriorating vision and speech, according to the National Institute of Neurological Disorders and Stroke, a branch of the National Institutes of Health. Children with the disease die between ages 5 and 10.
NBIA, sometimes called Hallervorden-Spatz syndrome, manifests itself between the teen years and adulthood. Symptoms include involuntary muscle contractions, rigidity and spasms in the limbs, face and torso, as well as confusion, disorientation, seizures, stupor and dementia. Rapid deterioration, punctuated by stable periods, lasts one to two months, with the rate of progression correlating with the patient's age – the later the onset, the better the patient fares. There is no cure nor standard treatment for either disease, which are inherited in a recessive fashion, meaning that both parents must contribute a defective gene to make both copies in the child defective. Incidence is 1 in 500,000 to 1 million.
PLA2G6's discovery means a clinical test can be developed to help families determine their chances of passing the disorders to their children.
"That's a direct outcome of this work," Hayflick said. "There are families who literally are waiting to have this test. They've been waiting for years. To have the option of bringing a child into this world you know won't have to suffer like this is extraordinary for a parent who's been through this. Some of them have had multiple children with the disease."
The disorders are caused by a build-up of iron in the basal ganglia, a cluster of gray-matter tissue structures deep in the brain that control motor function. The iron accumulation causes the branch-like axons that transmit electrical impulses from the nerve cell body to its terminal to swell, interrupting the signal sent to other nerve cells nearby.
PLA2G6 is thought to encode an enzyme that breaks down lipids involved in the reconstruction of a cell's membrane following damage by light and other toxins. When the gene is mutated, lipid metabolism is altered and iron builds up, triggering disease.
"I studied our entire INAD patient population for mutations in this gene and found over 44 different changes in the gene which would lead to disease," said study co-author Shawn Westaway, Ph.D., research assistant professor of molecular and medical genetics at OHSU. Working with scientists at the University of Birmingham School of Medicine, United Kingdom, Hayflick and Westaway collected DNA from 30 to 40 families affected by the diseases and narrowed the search for the suspect gene to a 100-gene block of DNA on chromosome 22, the second smallest chromosome in humans that contains 500 to 800 genes. The team then looked for genes in the region whose function was suggestive of the symptoms and parts of the body affected by the diseases, and the search was further narrowed to 75 genes.
"You just start sequencing genes and compare healthy people to people with the disease," Hayflick said. "In people with the disease, you see changes that are clearly disease causing."
After scouring the 75 genes, "we finally found mutations in PLA2G6 in a large kindred with multiple generations of affected individuals, and in three other smaller families," Westaway said.
The chromosomes containing the mutations are then compared to almost 200 control chromosomes not affected by the disease. "The severity of the mutation is usually a very good clue that the gene has been found," she said. "That evidence is confirmed by continuing to find different, but severe, mutations in the same gene in new patients diagnosed with INAD, which we have done."
PLA2G6 is among 18 lipid-metabolizing genes in a protein family known as phospholipase A2 (PLA2), and INAD is the first inherited disorder associated with mutations in one of these genes. Its discovery "unequivocally" links PLA2 defects to neurodegeneration, researchers say, which is significant because similar lipid metabolism changes are seen in neurodegeneration associated with ischemia from stroke, spinal cord trauma, head injury and Alzheimer's disease, making this metabolic pathway a potential drug target.
In addition, iron is known to accumulate with age in brain regions attacked by Alzheimer's and Parkinson's diseases. "This is a common end effect of many neurodegenerative disorders," Hayflick said.
Jonathan Modie | EurekAlert!
Nanoparticle Exposure Can Awaken Dormant Viruses in the Lungs
16.01.2017 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt
Cholera bacteria infect more effectively with a simple twist of shape
13.01.2017 | Princeton University
Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.
While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...
Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales
Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...
Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.
As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...
At TU Wien, an alternative for resource intensive formwork for the construction of concrete domes was developed. It is now used in a test dome for the Austrian Federal Railways Infrastructure (ÖBB Infrastruktur).
Concrete shells are efficient structures, but not very resource efficient. The formwork for the construction of concrete domes alone requires a high amount of...
Many pathogens use certain sugar compounds from their host to help conceal themselves against the immune system. Scientists at the University of Bonn have now, in cooperation with researchers at the University of York in the United Kingdom, analyzed the dynamics of a bacterial molecule that is involved in this process. They demonstrate that the protein grabs onto the sugar molecule with a Pac Man-like chewing motion and holds it until it can be used. Their results could help design therapeutics that could make the protein poorer at grabbing and holding and hence compromise the pathogen in the host. The study has now been published in “Biophysical Journal”.
The cells of the mouth, nose and intestinal mucosa produce large quantities of a chemical called sialic acid. Many bacteria possess a special transport system...
10.01.2017 | Event News
09.01.2017 | Event News
05.01.2017 | Event News
17.01.2017 | Earth Sciences
17.01.2017 | Materials Sciences
17.01.2017 | Architecture and Construction